JP2008289486A5 - - Google Patents

Download PDF

Info

Publication number
JP2008289486A5
JP2008289486A5 JP2008139534A JP2008139534A JP2008289486A5 JP 2008289486 A5 JP2008289486 A5 JP 2008289486A5 JP 2008139534 A JP2008139534 A JP 2008139534A JP 2008139534 A JP2008139534 A JP 2008139534A JP 2008289486 A5 JP2008289486 A5 JP 2008289486A5
Authority
JP
Japan
Prior art keywords
mammalian
astrocyte
cells
pdgf
oligodendrocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008139534A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008289486A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2008289486A publication Critical patent/JP2008289486A/ja
Publication of JP2008289486A5 publication Critical patent/JP2008289486A5/ja
Pending legal-status Critical Current

Links

JP2008139534A 2002-01-23 2008-05-28 星状細胞限定前駆細胞の純粋集団並びにその単離方法および使用 Pending JP2008289486A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35103602P 2002-01-23 2002-01-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003561348A Division JP2006503543A (ja) 2002-01-23 2003-01-23 星状細胞限定前駆細胞の純粋集団並びにその単離方法および使用

Publications (2)

Publication Number Publication Date
JP2008289486A JP2008289486A (ja) 2008-12-04
JP2008289486A5 true JP2008289486A5 (enExample) 2010-12-24

Family

ID=27613451

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003561348A Pending JP2006503543A (ja) 2002-01-23 2003-01-23 星状細胞限定前駆細胞の純粋集団並びにその単離方法および使用
JP2008139534A Pending JP2008289486A (ja) 2002-01-23 2008-05-28 星状細胞限定前駆細胞の純粋集団並びにその単離方法および使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2003561348A Pending JP2006503543A (ja) 2002-01-23 2003-01-23 星状細胞限定前駆細胞の純粋集団並びにその単離方法および使用

Country Status (8)

Country Link
US (4) US20050214940A1 (enExample)
EP (1) EP1476020A4 (enExample)
JP (2) JP2006503543A (enExample)
KR (1) KR20040075957A (enExample)
AU (1) AU2003216111C1 (enExample)
CA (1) CA2473749C (enExample)
NZ (1) NZ534381A (enExample)
WO (1) WO2003061392A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070171A2 (en) 2002-02-15 2003-08-28 Cornell Research Foundation, Inc. Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
US9709553B2 (en) 2008-05-08 2017-07-18 University Of Rochester Treating myelin diseases with optimized cell preparations
WO2014124087A1 (en) 2013-02-06 2014-08-14 University Of Rochester Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
US9724432B2 (en) * 2015-04-30 2017-08-08 University Of Rochester Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
WO2017172976A1 (en) * 2016-03-29 2017-10-05 The Regents Of The University Of California Methods for promoting oligodendrocyte regeneration and remyelination
JP7457505B2 (ja) 2017-05-10 2024-03-28 ユニバーシティー オブ ロチェスター 神経精神障害を処置する方法
CN113337469B (zh) * 2021-07-16 2023-03-24 广州市妇女儿童医疗中心 星形胶质细胞亚群及其分离纯化方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202120A (en) * 1987-09-11 1993-04-13 Case Western Reserve University Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes
US6204053B1 (en) * 1994-11-08 2001-03-20 Diacrin, Inc. Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
US5874301A (en) * 1994-11-21 1999-02-23 National Jewish Center For Immunology And Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6235527B1 (en) * 1997-11-29 2001-05-22 University Of Utah Research Foundation Lineage restricted glial precursors from the central nervous system
AU784513B2 (en) * 2000-01-18 2006-04-27 Board Of Trustees Of The Leland Stanford Junior University Expansion of stem and progenitor cells by beta-catenin
IL152741A0 (en) * 2000-05-17 2003-06-24 Geron Corp Neural progenitor cell populations
US7560280B2 (en) * 2000-11-03 2009-07-14 Kourion Therapeutics Gmbh Human cord blood derived unrestricted somatic stem cells (USSC)

Similar Documents

Publication Publication Date Title
JP2011206064A5 (enExample)
Martins et al. The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine
JP2008212150A5 (enExample)
WO2007030469A3 (en) Transplantable cell growth niche and related compositions and methods
Li et al. Agarose-based spheroid culture enhanced stemness and promoted odontogenic differentiation potential of human dental follicle cells in vitro: Li et al.
Morita et al. Metabolic regulation of cardiac differentiation and maturation in pluripotent stem cells: a lesson from heart development
Suzuki et al. Therapeutic efficacy of large aligned cardiac tissue derived from induced pluripotent stem cell in a porcine ischemic cardiomyopathy model
Alonaizan et al. Cardiac regeneration following myocardial infarction: the need for regeneration and a review of cardiac stromal cell populations used for transplantation
JP2013510570A5 (enExample)
JP2010166901A5 (enExample)
Nie et al. Improving the repopulation capacity of elderly human hepatocytes by decoding aging‐associated hepatocyte plasticity
Zhou et al. Design of chemically defined synthetic substrate surfaces for the in vitro maintenance of human pluripotent stem cells: a review
WO2009114673A2 (en) Methods for production of atrial progenitors and their differentiation into smooth muscle cells and cardiomyocytes
Generali et al. Generation and purification of iPSC-derived cardiomyocytes for clinical applications
Iwatani et al. Involvement of WNT signaling in the regulation of gestational age‐dependent umbilical cord‐derived mesenchymal stem cell proliferation
Hattori et al. Strategies for replacing myocytes with induced pluripotent stem in clinical protocols
WO2020200272A1 (zh) 人心肌细胞分离试剂、培养基、分离方法和培养方法
Oshima et al. Regeneration of complex oral organs using 3D cell organization technology
JP2009100702A5 (enExample)
EP3730604A1 (en) Method for producing sheet-like cell culture
CN105838604B (zh) 用于成熟脂肪细胞天花板培养的培养皿
Gao et al. Generating kidney organoids in suspension from induced pluripotent stem cells
Kubli et al. Eat, breathe, ROS: controlling stem cell fate through metabolism
CN102517248A (zh) 一种体外诱导胰岛样结构形成的方法
Tsujimura et al. Quality evaluation of cell spheroids for transplantation by monitoring oxygen consumption using an on-chip electrochemical device